@article{08d1bfbb8fe9485595513cb39e303897,
title = "Reporting considerations for cefepime-susceptible and -susceptible-dose dependent results for carbapenemase-producing enterobacterales",
keywords = "Antimicrobial susceptibility testing, Breakpoints, Carbapenemases, Cefepime, Enterobacterales, Enterobacteriaceae",
author = "Fissel, {J. A.} and Yarbrough, {M. L.} and T. Tekle and Burnham, {C. A.D.} and Simner, {P. J.}",
note = "Funding Information: P.J.S. has received grants and personal fees from Accelerate Diagnostics, OpGen, Inc., and BD Diagnostics; grants from bioMerieux, Inc., Affinity Biosensors, and Hardy Diagnostics; and personal fees from Roche Diagnostics and Shionogi, Inc. C.-A.D.B. receives research support from bioM?rieux, BioFire, Cepheid, and Luminex and consulting fees from Bio-Rad Laboratories and Thermo Fisher. M.L.Y. has a research relationship with Arkray and is a scientific advisor for Roche. Funding Information: P.J.S. has received grants and personal fees from Accelerate Diagnostics, OpGen, Inc., and BD Diagnostics; grants from bioMerieux, Inc., Affinity Biosensors, and Hardy Diagnostics; and personal fees from Roche Diagnostics and Shionogi, Inc. C.-A.D.B. receives research support from bioM{\'e}rieux, BioFire, Cepheid, and Luminex and con-",
year = "2020",
month = sep,
doi = "10.1128/JCM.01271-20",
language = "English",
volume = "58",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
number = "9",
}